PDS Biotechnology Corp (PDSB) Stock Analysis
Verdict: AVOID
Fresh PIPE capital extends runway for mCRC trials, but chronic pre-revenue cash burn and severe dilution risk make PDSB an avoid.
Investment score: 31/100
Analysis as of
Is PDS Biotechnology Corp stock worth reviewing? AI model thesis
The model recommends AVOID for PDS Biotechnology Corp due to severe cash burn, ongoing share dilution, and pre-revenue execution risks, despite temporary momentum from its recent PIPE financing.
7-factor investment score
- Valuation: 20/100 (weight 20%)
- Financial Health: 15/100 (weight 15%)
- Technical Momentum: 45/100 (weight 15%)
- Earnings Quality: 30/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 60/100 (weight 10%)
- Risk-Adjusted Return: 25/100 (weight 15%)
PDS Biotechnology Corp opportunities and risks
What speaks for PDSB
- PIPE Capital Infusion and Strategic Partner
What speaks against PDSB
- Inadequate Cash Runway and Imminent Dilution
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| PDSB | n/a | 0.0x | n/a | 0.0% | 0.0% | -25.0% |
| FBIO | 0.6x | 1.0x | n/a | 62.5% | 163.3% | 181.3% |
| XBIT | n/a | 0.0x | 1.0x | 0.0% | 0.0% | -61.4% |
| IBIO | n/a | 720.2x | n/a | 100.0% | -33044.0% | -33.0% |
| APLM | n/a | 5.9x | n/a | 100.0% | -128.7% | -20.5% |
| SPRO | 8.3x | 1.6x | 2.4x | 100.0% | 17.2% | 29.2% |
| Peer median | n/a | 1.6x | n/a | 100.0% | 0.0% | -20.5% |
Frequently asked questions about PDS Biotechnology Corp (PDSB)
Is PDSB stock a good investment?
The cached TradeMates AI model rates PDS Biotechnology Corp as AVOID with an investment score of 31/100. The model recommends AVOID for PDS Biotechnology Corp due to severe cash burn, ongoing share dilution, and pre-revenue execution risks, despite temporary momentum from its recent PIPE financing. This is algorithmic model output, not personal investment advice.
Is PDSB stock a buy?
The TradeMates model verdict for PDSB is AVOID with an investment score of 31/100. Treat this as a model signal to review, not a personal buy recommendation.